Jacques O. Bay

Clermont-ferrand, FR 
Clermont-ferrand, FR 

Overview

Jacques Bay practices practicing medicine in Clermont-ferrand, France.

His clinical expertise encompasses Angiosarcoma, B-Cell Lymphoma, Adult Soft Tissue Sarcoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Clermont-ferrand, France
Other Locations
Hospices Civils de Lyon, Pierre Bénite
Lyon, France
Tours, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Trial Evaluating Glofitamab, a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
A Phase II Trial Evaluating Glofitamab, a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Enrollment Status: Completed
Publish Date: March 16, 2026
Intervention Type: Drug
Study Drugs: Obinutuzumab, RO7082859
Study Phase: Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Low or Intermediate-1 Myelodysplastic Syndrome: A Prospective Multicenter Phase II Study Based on Donor Availability on Behalf of the GFM & SFGM-TC
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Low or Intermediate-1 Myelodysplastic Syndrome: A Prospective Multicenter Phase II Study Based on Donor Availability on Behalf of the GFM & SFGM-TC
Enrollment Status: Completed
Publish Date: August 02, 2024
Intervention Type: Other
Study Phase: Not Applicable
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
Enrollment Status: Terminated
Publish Date: June 22, 2021
Intervention Type: Genetic, Other
Study Phase: Phase 3
View 2 Less Clinical Trials

16 Total Publications

Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.
Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 24, 2026

Frequently Asked Questions about Jacques O. Bay

Is Jacques O. Bay a top-rated expert for Angiosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jacques O. Bay is classified as an Experienced expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jacques O. Bay participate in research or clinical trials?

Yes. Jacques O. Bay has published 16 articles and abstracts on conditions like Angiosarcoma. You can view a list of Jacques O. Bay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bay's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile